These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11794470)

  • 1. Effect of norethindrone acetate on hormone levels and markers of bone turnover in estrogen-treated postmenopausal women.
    Onobrakpeya OA; Fall PM; Willard A; Chakravarthi P; Hansen A; Raisz LG
    Endocr Res; 2001 Nov; 27(4):473-80. PubMed ID: 11794470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G; Hansen A; Prestwood KM
    Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
    Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
    Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
    Taxel P; Kennedy D; Fall P; Willard A; Shoukri K; Clive J; Raisz LG
    Endocr Res; 2000 Aug; 26(3):381-98. PubMed ID: 11019903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic effects of delta-8-estrone sulfate in postmenopausal women.
    Bhavnani BR; Cecutti A; Dey MS
    J Soc Gynecol Investig; 1998; 5(3):156-60. PubMed ID: 9614646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study.
    Coelingh Bennink HJT; Verhoeven C; Zimmerman Y; Visser M; Foidart JM; Gemzell-Danielsson K
    Menopause; 2017 Jun; 24(6):677-685. PubMed ID: 28169916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of two dosages of a continuous combined hormone replacement regimen.
    Loh FH; Chen LH; Yu SL; Jorgensen LN
    Maturitas; 2002 Feb; 41(2):123-31. PubMed ID: 11836043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
    Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
    Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
    Campagnoli C; Colombo P; De Aloysio D; Gambacciani M; Grazioli I; Nappi C; Serra GB; Genazzani AR
    Maturitas; 2002 Apr; 41(4):299-311. PubMed ID: 12034517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study.
    Arabi A; Garnero P; Porcher R; Pelissier C; Benhamou CL; Roux C
    Hum Reprod; 2003 Aug; 18(8):1747-52. PubMed ID: 12871894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L; Naessén T; Eriksson K; Rune C
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor.
    Couzinet B; Young J; Brailly S; Chanson P; Thomas JL; Schaison G
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4218-23. PubMed ID: 8954018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
    Nguyên-Pascal ML; Thomas JL; Bergougnoux L; Garnero P; Drapier-Faure E; Delmas PD
    Climacteric; 2005 Jun; 8(2):136-45. PubMed ID: 16096169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: A randomized, placebo-controlled, double-blind trial.
    Costa-Paiva L; O Wender MC; Machado RB; Pompei LM; Nahas EA; Nahas-Neto J; Del Debbio SY; Badalotti M; Cruz AM
    Post Reprod Health; 2022 Sep; 28(3):149-157. PubMed ID: 35938207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.